SUN PHARMA /TARO recalls Lidocaine Ointment USP
- Recalling company
- SUN PHARMA /TARO
- Product
- Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5
- Reason
- Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Aug 31, 2026
- Reported
- Sep 23, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 65,328 50g jars
- Lot / codes
- Lot # AD48154, Exp: 4/30/2027.
- Company location
- Hawthorne, NY
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0848-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0848-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.